G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| P00533 | Epidermal growth factor receptor | ||
| P00558 | Phosphoglycerate kinase 1 | ||
| P00738 | Haptoglobin | ||
| P00815 | Histidine biosynthesis trifunctional protein | ||
| P00915 | Carbonic anhydrase 1 | ||
| P00931 | Tryptophan synthase | ||
| P00966 | Argininosuccinate synthase | ||
| P01009 | Alpha-1-antitrypsin | ||
| P01011 | Alpha-1-antichymotrypsin | ||
| P01019 | Angiotensinogen |
| Pathway Name | Organism |
|---|---|
| E.coli O4-H5 | Escherichia coli |
| E.coli O4-K52 | Escherichia coli |
| E.coli O40 | Escherichia coli |
| E.coli O41 | Escherichia coli |
| E.coli O42 | Escherichia coli |
| E.coli O45rel | Escherichia coli |
| E.coli O48 | Escherichia coli |
| E.coli O53 | Escherichia coli |
| E.coli O55 | Escherichia coli |
| E.coli O56 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 37328468 | Structure and antigenicity of divergent Henipavirus fusion glycoproteins | Isaacs A | 2023 Jun 16 |
|
| 37322000 | Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection | Guo Y | 2023 Jun 15 |
|
| 37318226 | The avidin‐theophylline complex: A structural and computational study | Spinello A | 2023 Jun 15 |
|
| 37308732 | Direct stimulation of de novo nucleotide synthesis by O-GlcNAcylation | Chen L | 2023 Jun 12 |
|
| 37062240 | Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2 | Chu X | 2023 Jun 11 |
|
| 37285422 | Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity | Williams JA | 2023 Jun 09 |
|
| 37286794 | Structural insights into dimerization and activation of the mGlu2–mGlu3 and mGlu2–mGlu4 heterodimers | Wang X | 2023 Jun 08 |
|
| 37295404 | Vaccine elicitation and structural basis for antibody protection against alphaviruses | Sutton MS | 2023 Jun 08 |
|
| 37279271 | A specialized integrin-binding motif enables proTGF-β2 activation by integrin αVβ6 but not αVβ8 | Le VQ | 2023 Jun 06 |
|
| 37276407 | Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins | Misson Mindrebo L | 2023 Jun 05 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025